Inclusion of ORCID iDs in pharma-affiliated publications

<div>In this secondary analysis, we assessed the impact of changes</div><div>to the publishing workflow on the submission of ORCID iDs by</div><div>pharma-affiliated authors compared with non-pharma-affiliated</div><div>authors across a sample of Future Science Group journals.</div>